Twelve researchers from the University of Sydney have been included in the 2018 Clarivate Analytics Highly Cited Researchers List.
The Clarivate Analytics 2018 Highly Cited Researchers List recognised more than 4,000 leading researchers in 21 fields of the sciences and social sciences from around the world, including 17 Nobel laureates.
Now in its fifth year, the annual list identifies influential researchers having the greatest impact on the research community as measured by the rate at which their work is being cited by their peers around the globe. The Web of Science serves as the basis for regular listings of researchers whose citation records position them in the top 1 percent by citations for their field and year.
The 12 researchers were recognised in categories including agricultural sciences, chemistry, clinical medicine, computer science, economics and business, engineering, microbiology, neuroscience and behaviour, social sciences and cross-field.
The new cross-field category was added this year to recognise researchers with substantial influence in several fields but who do not have enough highly cited papers in any one field to be chosen. Three of the University of Sydney researchers were named in the cross-field category.
The Highly Cited Researcher List is used by the Academic Ranking of World Universities (ARWU) to calculate an institution’s Highly Cited score and contributes to its overall institutional score. In 2018, the University of Sydney climbed 15 places, its best result since the ARWU rankings began in 2003.
Our 2018 highly cited scholars
For more than 30 years Professor Bauman has been a world leader in the study of chronic disease prevention and the development and assessment of prevention research methods. He was instrumental in identifying the health benefits of moderate physical activity and reduced sitting time. He has published more than 525 papers and two books.
Professor Gale’s work has potential future use in the treatment of diseases that are caused by faulty anion transport such as cystic fibrosis and also in the treatment of cancer. Earlier this year he was awarded the prestigious Izatt-Christensen Award for his seminal contributions to the field. He has published more than 250 papers and been named in highly cited researcher lists since 2012.
Professor Halliday leads a research program of approximately 70 researchers tackling non-Alzheimer's neurodegeneration. She is on
